Symbiosis Pharmaceuticals Private Limited, a active private limited company, was established on 04 April 2003 in Naraingarh, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239HR2003PTC035085. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹7.93 Cr.
Formerly known as Symbiosis Pharmaceutical Private Limited. It upholds a compliant status. Employing 47 professional, Its leadership includes Harnek Singh (Director), Jagbir Singh (Director), Sheetal Dass (Director). Past directors included Hukam Malik Chand, Jagbir Singh, Vishwambhar Dayal Gupta. It holds ₹65.89 Cr open charges and ₹12.37 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House Number 341, Sector 4, Urban Estate,, Naraingarh, Haryana, 134203.
U24239HR2003PTC035085
035085
04 April 2003
₹10.00 Cr
₹7.93 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Symbiosis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harnek Singh | Director | 12 Apr 2021 | Current |
| Jagbir Singh | Director | 04 Apr 2003 | Current |
| Sheetal Dass | Director | 30 Jun 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Feb 2007 | Past |
| Pramod Abcsdd | Managing Director | 01 May 2017 | Past |
| Pramod Abcsdd | Director | 15 Mar 2025 | Past |
| Pramod Abcsdd | Director | 01 Oct 2008 | Past |
| Pramod Abcsdd | Manager | 31 Dec 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Symbiosis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.61% decrease. The company also saw a slight improvement in profitability, with a 0.17% increase in profit. The company's net worth moved up by a moderate rise of 6.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Symbiosis Pharmaceuticals had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹658,937,834.00
₹123,652,059.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2025 | Sidbi | ₹4.55 M | Open |
| 12 Jun 2025 | State Bank Of India | ₹5.60 M | Open |
| 17 Mar 2025 | Sidbi | ₹4.00 M | Open |
| 28 Feb 2025 | Sidbi | ₹2.06 Cr | Open |
| 08 Jan 2025 | Sidbi | ₹1.35 Cr | Open |
Explore comprehensive loan charge details -
Symbiosis Pharmaceuticals has a workforce of 47 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Symbiosis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbiosis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Sidbi amounted to Rs. 0.46 Cr with Charge ID 101167623 was registered on 16 Sep 2025. was recorded as a recent event.
Progress on A charge with State Bank Of India amounted to Rs. 0.56 Cr with Charge ID 101111661 was registered on 12 Jun 2025. was documented.
The activity A charge with Sidbi amounted to Rs. 0.40 Cr with Charge ID 101087329 was registered on 17 Mar 2025. was completed.
Progress on A charge with Sidbi amounted to Rs. 2.06 Cr with Charge ID 101083710 was registered on 28 Feb 2025. was documented.
The activity A charge with Sidbi amounted to Rs. 1.35 Cr with Charge ID 101037440 was registered on 08 Jan 2025. was completed.
A charge registered on 29 Apr 2019 via Charge ID 100271168 with Hdfc Bank Limited was fully satisfied on 22 Nov 2024. was recorded as a recent event.
The CIN of Symbiosis Pharmaceuticals Private Limited is U24239HR2003PTC035085.
Symbiosis Pharmaceuticals Private Limited is headquartered at House Number 341, Sector 4, Urban Estate,, Naraingarh, Haryana, 134203.
Symbiosis Pharmaceuticals Private Limited was incorporated on 04 April 2003.
The current directors of Symbiosis Pharmaceuticals Private Limited are
The primary industry of Symbiosis Pharmaceuticals Private Limited is Manufacturing.
Symbiosis Pharmaceuticals Private Limited is unlisted.
The authorized capital of Symbiosis Pharmaceuticals Private Limited is ₹10.00 Cr, and the paid-up capital is ₹7.93 Cr.
The compliance status of Symbiosis Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX